- Home
- YQ vs NXL Comparison
YQ vs NXL Comparison
Compare YQ & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YQ
- NXL
- Stock Information
- Founded
- YQ 2012
- NXL 2010
- Country
- YQ China
- NXL United States
- Employees
- YQ N/A
- NXL N/A
- Industry
- YQ Other Consumer Services
- NXL Medical Specialities
- Sector
- YQ Real Estate
- NXL Health Care
- Exchange
- YQ Nasdaq
- NXL Nasdaq
- Market Cap
- YQ 12.1M
- NXL 10.0M
- IPO Year
- YQ 2020
- NXL 2022
- Fundamental
- Price
- YQ $1.67
- NXL $3.16
- Analyst Decision
- YQ
- NXL Hold
- Analyst Count
- YQ 0
- NXL 1
- Target Price
- YQ N/A
- NXL N/A
- AVG Volume (30 Days)
- YQ 12.7K
- NXL 445.0K
- Earning Date
- YQ 12-11-2024
- NXL 11-08-2024
- Dividend Yield
- YQ N/A
- NXL N/A
- EPS Growth
- YQ N/A
- NXL N/A
- EPS
- YQ N/A
- NXL N/A
- Revenue
- YQ $28,507,378.00
- NXL $162,078.00
- Revenue This Year
- YQ N/A
- NXL $56.86
- Revenue Next Year
- YQ N/A
- NXL $167.44
- P/E Ratio
- YQ N/A
- NXL N/A
- Revenue Growth
- YQ 22.55
- NXL 26.00
- 52 Week Low
- YQ $1.50
- NXL $0.25
- 52 Week High
- YQ $3.20
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- YQ 45.54
- NXL 51.05
- Support Level
- YQ $1.59
- NXL $2.55
- Resistance Level
- YQ $1.86
- NXL $3.11
- Average True Range (ATR)
- YQ 0.08
- NXL 0.32
- MACD
- YQ 0.01
- NXL 0.03
- Stochastic Oscillator
- YQ 36.30
- NXL 70.71
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.